Buparlisib (BKM-120)

buparlisib · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Buparlisib (BKM-120), covering 2018-05-24 to 2018-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma [Phase 1, Phase 2]